Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease
Journal of Biological Chemistry · 2025-09 · 301 (9) · 110583
DOI: 10.1016/j.jbc.2025.110583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-09. Verfasst von Junjie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Science and Engineering, Tongji University, Shanghai, PR China. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Chelating Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Tau aggregation inhibitors or neurotoxic-metal chelators have been extensively studied as potential treatment for Alzheimer's disease. However, it is a great challenge to improve their therapeutic effects while reducing neurotoxicity. Herein, we designed and synthesized two new compounds, (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis((3,4,5-trihydroxyphenyl)methanone) (4GA) and (4,10-dimethyl-1,4,7,10-tetraazacyclododecane-1,7-diyl)bis((3,4,5-trihydroxyphenyl)methanone) (2GA). Each molecule is composed of a 1,4,7,10-tetraazacyclododecane (cyclen) core as the supramolecular chelator to copper ions, attached by 2 or 4GAllic acid polyphenol arms to capture tau peptide chain like a molecular hairpin. We interestingly found that 4GA and 2GA could inhibit self-aggregation through blocking the misfolding of tau peptide, suppress the promotion of Cu2+ on tau aggregation by removing Cu2+ from dyshomeostasis, and clear reactive oxygen species triggered by Cu2+ using their reductive gallic acid groups. More significantly, the synthesized compounds exhibit remarkable efficiency on both in vitro and at cellular level. Our rational design of multifunctional therapeutic agent that simultaneously targets tau misfolding process, copper dyshomeostasis, and oxidative stress of reactive oxygen species, may hold considerable implications for the treatment of Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Science and Engineering, Tongji University, Shanghai, PR China.
- Department of Neurology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, PR China. Electronic address: liujihong@5thhospital.com.
- School of Chemical Science and Engineering, Tongji University, Shanghai, PR China; Ningxia Key Laboratory of Green Catalytic Materials and Technology, College of Chemistry and Chemical Engineering, Ningxia Normal Univer…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Chai, K., Tu, Y., Fang, K., Shi, S., Hu, X., Liu, J., & Yao, T. (2025). Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease. Journal of Biological Chemistry, 301(9), 110583. https://doi.org/10.1016/j.jbc.2025.110583
Vancouver
Wu J, Chai K, Tu Y, Fang K, Shi S, Hu X, et al. Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease. Journal of Biological Chemistry. 2025;301(9):110583. doi:10.1016/j.jbc.2025.110583
BibTeX
@article{Wu2025,
author = {Wu, Junjie and Chai, Keke and Tu, Ying and Fang, Kang and Shi, Shuo and Hu, Xiaochun and Liu, Jihong and Yao, Tianming},
title = {Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {9},
pages = {110583},
doi = {10.1016/j.jbc.2025.110583}
}
EUVIMED